Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBlue Cross Blue Shield WI Prior Auth Code List | O…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBlue Cross Blue Shield - WisconsinPolicy N/A

    Items and services requiring prior authorization

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Wisconsin policy alerts

    Know when Blue Cross Blue Shield - Wisconsin releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This document lists specific procedure codes and descriptions for items and services that require prior authorization from Blue Cross Blue Shield - Wisconsin. It affects providers and facilities submitting claims for the listed Medicare procedure codes.

    Policy Summary
    PayerBlue Cross Blue Shield - Wisconsin
    PolicyItems and services requiring prior authorization
    Policy CodePolicy N/A
    Change TypeAdministrative update (no material coverage change)
    Effective DateFeb 11, 2026
    Last ReviewFeb 11, 2026
    Next Review DateFeb 11, 2026
    Key ActionObtain prior authorization before providing or submitting claims for any procedure code listed in this document.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    40+procedure codes listed (partial)
    ~150+unique procedure codes (partial)
    2/11/2026document update
    Genomic testsprimary test types
    100+
    injectable J-codes (segment)

    Items and Services Requiring Prior Authorization

    Prior authorization list (partial)

    Procedure codes listed in this segment require prior authorization.

    ALL of the following

    • Listed procedure codes: Codes and descriptions enumerated in this segment (including CPT, HCPCS, PLA/U-codes and other Medicare procedure codes) require prior authorization before services are provided.
    • Examples

      • Therapeutic and rehabilitation codes (e.g., 97129, 97110, 97035) are included on the prior authorization list.
      • Genomic and molecular testing U-codes (e.g., 0075U, 0242U, 0560U) are included on the prior authorization list.

    ALL of the following

    • Providers must request prior authorization for items and services that match the listed procedure codes in this segment (see full policy for submission instructions).

    Prior authorization requirement list (partial)

    Listed procedure codes require prior authorization; examples across oncology, rare disease, pharmacogenomics, prenatal testing, and cytogenetics are included.

    ALL of the following

    • Oncology genomic tests: Codes for oncology genomic analyses and panels (examples: 0318U, 0314U, 0300U, 0379U, 0569U) require prior authorization.
    • Rare disease / hereditary tests: Codes for rare disease or constitutional/heritable disorder sequence analysis (examples: 0567U, 0336U, 0264U, 0469U) require prior authorization.
    • Pharmacogenomics / drug metabolism: Drug metabolism/pharmacogenomics panels (examples: 0075U, 0074U, 0533U) require prior authorization.
    • Prenatal testing: Prenatal and carrier screening entries (examples: 0449U, 0488U, 0494U) require prior authorization.

    Prior authorization list (excerpt)

    Items and services listed below require prior authorization. Specific clinical criteria and submission requirements are not included in this excerpt.

    ALL of the following

    • Single-gene and multi-gene tests: Numerous single-gene tests (e.g., 81235, 81233, 81302) and multigene/genomic tests (e.g., 81403, 81599, 0019U) are listed as requiring prior authorization.
    • Multianalyte and algorithmic assays: Unlisted multianalyte assays with algorithmic analysis (e.g., 81599, 0019U, 0016M) require prior authorization.

    ALL of the following

    • Clinical coverage criteria and documentation instructions are not included in this excerpt; prior authorization approval depends on the full policy's clinical rules.

    Prior authorization requirement — code list

    Codes and descriptions that require prior authorization (excerpt):

    ALL of the following

    • Genetic/Molecular Tests: Specific HCPCS/U-code entries shown (examples: 0469U: whole genome sequence for chromosomal abnormalities; 0465U: DNA methylation/oncology assay; 0454U: optical structural variant identification) require prior authorization.
    • Other listed U-codes: Additional U-code molecular assays and prenatal/rare-disease tests (e.g., 0488U, 0478U, 0536U, 0534U) require prior authorization.

    ALL of the following

    • Providers must obtain prior authorization for services billed with the above codes; consult the full policy for clinical criteria and submission requirements.

    Prior authorization stance for listed codes

    Codes listed below in this document segment require prior authorization.

    ALL of the following

    • Targeted genomic panels of varying gene counts (examples: 0571U, 0565U, 0388U) are listed and require prior authorization.
    • Drug metabolism and pharmacogenomic panels (examples: 0070U, 0533U) are listed and require prior authorization.
    • Therapeutic injectable and oncology J-codes (examples shown elsewhere in the document) are included in the prior authorization requirement for this segment.

    ALL of the following

    • This excerpt provides stance that the listed molecular tests, injections, biosimilars, immune globulins, and radiation/procedure codes are subject to prior authorization; specific clinical decision rules are in the full policy.

    Prior authorization code list (part 6)

    Codes and descriptions requiring prior authorization (partial list from document part 6).

    ALL of the following

    • Injectable biologics & immune globulins: Multiple injectable medications and immune globulins (examples: J1568, J9312, J9308, J9024) are listed as requiring prior authorization.
    • Radiation & brachytherapy: Radiation delivery and brachytherapy codes (examples: 77412, 77301, 77778, 77432, 77435) require prior authorization.
    • Complex procedures & devices: Placement and device-related procedure codes (examples: 41019, C9804, E2228) require prior authorization.

    ALL of the following

    Prior Authorization Code Set (partial)

    Codes and descriptions listed require prior authorization per the payer policy.

    ALL of the following

    • Behavioral and testing services: Psychological and neuropsychological testing and administration codes (e.g., 96138, 96139, 96136, 96137, 96130) require prior authorization.
    • DME, wound and implantable devices: Examples including adhesive clips, enteral pumps, cryoablation needles, and specialized wound systems (e.g., A4438, B9004, C9809, A2020) require prior authorization.
    • Selected drug and procedural codes: Select drug injections and procedural codes listed (examples: J2507, J9273, 33249, 21146) require prior authorization.

    ALL of the following

    Prior authorization code list (partial)

    The document identifies items and services that require prior authorization; no clinical coverage criteria or decision rules are included in these chunks — only code and description listings.

    ALL of the following

    • Sample entries in this segment include specialty drug J-codes (e.g., J1743, J1809, J2469) and DME/orthotics codes (e.g., K0007, K0043) which are listed as requiring prior authorization.
    • Because this excerpt contains only code/descriptions, clinicians must consult the full policy for approval criteria and required documentation.

    ALL of the following

    • Prior authorization is required for the listed items before provision or claim submission; see payer's authorization portal for instructions.

    Prior authorization required — code list (partial)

    Codes listed below require prior authorization per this policy document (partial list from chunks 144–163).

    ALL of the following

    • Power wheelchairs & prosthetics: Power wheelchair group codes and multiple L-/K- and custom prosthetic codes (examples: K0849, K0859, L6880, L7009) require prior authorization.
    • Amniotic/biologic wound products & biosimilars: Amniotic/biologic wound product Q-codes and biosimilar Q-codes (examples: Q4225, Q4366, Q5108, Q4200) require prior authorization.

    ALL of the following

    • This is a partial excerpt; clinical criteria for coverage (such as unit measures per sq cm for biologic products) are defined elsewhere in the full policy and must be consulted when submitting authorization requests.

    Prior authorization required — code list (partial)

    Codes listed below require prior authorization. Specific clinical or documentation criteria for approval are not present in this excerpt and must be retrieved from other parts of the policy.

    ALL of the following

    • Amniotic/biologic products & biosimilars: Multiple Q-codes for amniotic/biologic wound products (e.g., Q4366, Q4367, Q4200) and biosimilar injections (e.g., Q5099, Q5100, Q5108) require prior authorization.
    • CAR-T / cell therapies: CAR-T and related cell therapy Q-codes (e.g., Q2042, Q2053, Q2055) require prior authorization; per-code therapeutic dose/cell count limits are shown elsewhere in the policy.
    • Prosthetics and orthotics: A broad set of L-codes for prosthetics and orthotics are listed as requiring prior authorization (examples appear in the fuller code listing).

    ALL of the following

    Prior authorization requirement — code list (partial)

    Codes listed below each require prior authorization per the payer's policy.

    ALL of the following

    • Power mobility & accessories: Power wheelchair and power mobility device codes (examples: K0886, K0890, K0891, K0899, K1007) require prior authorization.
    • Injectable drugs & biologics: Multiple injectable drug J-codes (examples: J9210, J9216, J9248, J9334) are included on the prior authorization list.
    • Speech generating and seating devices: Speech generating devices and wheelchair seating/cushion codes (examples: E2506, E2508, E2602, E2613) require prior authorization.

    ALL of the following

    Prior authorization requirement by code list

    Codes listed in this section require prior authorization as indicated by the policy update.

    ALL of the following

    • Wheelchair accessories: Power wheelchair accessory items (e.g., E2390 foam caster tire, E2391 solid caster tire) are listed as requiring prior authorization.
    • Implants, neurostimulators, infusion pumps: Implantable device, neurostimulator and infusion pump related codes (examples: C9807, C1820, B9002) require prior authorization.

    ALL of the following

    • The policy update date appears on these chunks (Updated: 2/11/2026); providers should reference the current policy version when submitting prior authorization requests.

    Prior Authorization Required Items (partial list)

    Procedures and supplies in this list require prior authorization per the payer.

    ALL of the following

    • Transplant and major surgical procedures: Major transplant and mechanical circulatory support procedures (examples: 47135, 33935, 44132) require prior authorization.
    • Hematopoietic and apheresis services: Hematopoietic progenitor cell harvesting and related transplant codes (e.g., 38232, 38240, 36482) require prior authorization.
    • Specialized imaging and radiopharmaceuticals: Radiopharmaceutical and advanced imaging therapeutic codes (examples: A9543, A9607, C9762) require prior authorization.

    ALL of the following

    Prior Authorization Code List (partial)

    Codes listed below require prior authorization. The list includes procedure codes (T-codes, CPT), HCPCS/J-codes, and other identifiers.

    ALL of the following

    • Device implantation & interrogation T-codes: T-code entries for device implantation and interrogation (examples: 0916T, 0926T, 0928T) require prior authorization.
    • Advanced surgical and graft procedures: Advanced reconstructive and graft procedures (examples: 15152, 15842) are included and require prior authorization.
    • Cardiac contractility modulation systems: Cardiac contractility modulation implant and related programming/removal codes (e.g., 0916T–0949T series) require prior authorization.

    ALL of the following

    Prior authorization required codes (partial)

    Codes and descriptions listed require prior authorization.

    ALL of the following

    • Interventional and ablative procedures: Percutaneous cryoablation, vascular embolization/occlusion, neurolytic procedures, and related interventional codes (examples: 0440T, 37243, 64640, 62280) require prior authorization.
    • Advanced imaging and device codes: Noninvasive FFR from CT, MR spectroscopy, and complex device insertion codes (examples: 75580, 76390, 64561) are included and require prior authorization.

    ALL of the following

    • Authorization approval depends on the full policy's clinical criteria; this excerpt includes representative procedure listings only.

    Code Tables and Examples

    Therapy/Physical Medicine codesCPTCovered
    97110Therapeutic exercises, each 15 min
    97035Ultrasound, each 15 min
    97164Reevaluation of physical therapy established plan of care
    Genomic and molecular testing (U-codes)CPTCovered
    0242UTargeted genomic sequence analysis panel, cell-free circulating DNA (55-74 genes)
    0332UOncology (pan-tumor), genetic profiling of 8 DNA-regulatory markers
    0350UDrug metabolism whole blood/buccal, 27 gene report
    Selected procedure codes in excerptmixedCovered
    0318UPediatrics, whole genome methylation analysis by microarray
    0314UOncology (cutaneous melanoma), mRNA gene expression profiling
    0300UOncology (pan tumor), whole genome sequencing and optical genome mapping
    81162BRCA1/BRCA2 full sequence and duplication/deletion analysis
    81223CFTR full gene sequence
    Examples of listed procedure codesCPT | PLA | mixed
    81235EGFR gene analysis, common variants
    81425Genome sequence analysis
    0215UWhole exome and mitochondrial DNA sequence analysis (rare diseases), comparator exome
    Selected molecular/genetic procedure codes in listmixed
    81552mRNA gene expression profiling (uveal melanoma)
    81525mRNA gene expression profiling (colon)
    81307PALB2 full gene sequence
    Selected cell-free DNA and expression assaysmixed
    81462Genomic sequence analysis panel, cell-free nucleic acid (plasma)
    81518Breast mRNA gene expression profiling (11 genes)
    Molecular/genetic tests (CPT/HCPCS/U-codes)mixedCovered
    0571UOncology (solid tumor), DNA (80 genes) and RNA (10 genes), by next-generation sequencing, plasma
    0565UOncology (hepatocellular carcinoma), NGS methylation pattern assay, cell-free DNA
    0388UOncology (non-small cell lung cancer), NGS identifying SNVs, CNVs, indels
    81216BRCA2 gene analysis; full sequence analysis
    81449Targeted genomic sequence analysis panel, solid organ neoplasm, 5-50 genes
    81337SMN1 gene analysis; known familial sequence variant(s)
    Therapeutic injections, biosimilars, immune globulinsmixedCovered
    J9035Bevacizumab injection
    J9317Sacituzumab govitecan-hziy, 2.5 mg
    J9301Obinutuzumab, 10 mg
    Q5110Filgrastim-aafi (biosimilar), 1 microgram
    Q5107Bevacizumab-awwb (biosimilar), 10 mg
    J1568Immune globulin (Octagam), IV, 500 mg
    J9312Rituximab, 10 mg
    J9024Atezolizumab, 5 mg with hyaluronidase
    Q5111Pegfilgrastim-cbqv (biosimilar), 0.5 mg
    Radiation and procedure codesCPTCovered
    77412Radiation treatment delivery, 3 or more separate treatment areas
    77301Intensity Modulated Radiotherapy Plan W/Dose Volume Histograms
    41019Placement of needles, catheters, or other device(s) into the head and/or neck region
    Selected injectable drug J-codesHCPCSCovered
    J1568Injection, immune globulin (Octagam), intravenous, nonlyophilized, 500 mg
    J9312Injection, rituximab, 10 mg
    J9308Injection, ramucirumab, 5 mg
    Selected radiation and brachytherapy codesCPTCovered
    77412Radiation treatment delivery, 3 or more separate treatment areas, custom blocking
    77301Intensity Modulated Radiotherapy Plan W/Dose Volume Histograms
    77778Interstitial Radioelement Application; Complex
    Selected DME/E-codesHCPCSCovered
    E2228Manual wheelchair accessory, wheel braking system and lock, complete, each
    E0466Home ventilator, any type, used with non-invasive interface
    Examples of codes requiring prior authorization in this partmixedCovered
    96138Psychological or neuropsychological test administration and scoring by technician, first 30 minutes
    96139Each additional 30 minutes (psych test admin by technician)
    A4438Adhesive clip applied to the skin to secure external electrical nerve stimulator controller
    J3398Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
    J0175Injection, donanemab-azbt, 2 mg
    K0830POWER WHEELCHAIR, GROUP 2 STANDARD, SEAT ELEVATOR...
    Sample drug/procedure codes from listmixed
    J1743Galsulfase, 1 mg
    J1809Idursulfase, injection, 1 mg
    J2469Palonosetron HCl
    Sample durable medical equipment and drug codesmixed
    K0802POWER OPERATED VEHICLE, GROUP 1 VERY HEAVY DUTY, PATIENT WEIGHT CAPACITY 451 TO 600 POUNDS
    K0826POWER WHEELCHAIR, GROUP 2 VERY HEAVY DUTY, SLING/SOLID SEAT/BACK, PATIENT WEIGHT CAPACITY 451 TO 600 POUNDS
    J2277Motixafortide injection, 0.25 mg
    Representative Q- and J-codes requiring prior authorizationmixed
    Q4200SkinTE, per sq cm
    Q4342TheraMend, per sq cm
    J0485Injection, belatacept, 1 mg
    Amniotic/biologic wound productsmixed
    Q4366Dual Layer Amnio Burgeon X-Membrane, per sq cm
    Q4367AmnioCore SL, per sq cm
    Q4369Amnioplast 3, per square centimeter
    Q4391AmnioPlast Double, per sq cm
    Q4183Surgigraft, per sq cm
    Q4200SkinTE, per sq cm
    Biosimilar injectablesmixed
    Q5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
    Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
    Q5108Injection, pegfilgrastim-jmdb (fulphila), 0.5 mg
    CAR-T therapiesmixed
    Q2042Tisagenlecleucel, up to 600 million CAR-positive viable T cells
    Q2053Brexucabtagene autoleucel, up to 200 million CAR-positive viable T cells
    Power wheelchairs / power-operated vehiclesHCPCS
    K0838Power wheelchair, group 2 heavy duty
    K0842Power wheelchair, group 2 standard
    K0899Power mobility device, not coded by DME PDAC or does not meet criteria
    K0800Power operated vehicle, group 1 standard
    Power wheelchair / mobilityHCPCSCovered
    K0886POWER WHEELCHAIR, GROUP 4 HEAVY DUTY, MULTIPLE POWER OPTION, SLING/SOLID SEAT/BACK
    K0890POWER WHEELCHAIR, GROUP 5 PEDIATRIC, SINGLE POWER OPTION
    K0891POWER WHEELCHAIR, GROUP 5 PEDIATRIC, MULTIPLE POWER OPTION
    K0898POWER WHEELCHAIR, NOT OTHERWISE CLASSIFIED
    K0899Power mobility device, not coded by DME PDAC or does not meet criteria
    Injectable drugs / biologicsHCPCSCovered
    J9210Injection, emapalumab-lzsg, 1 mg
    J9319Injection, romidepsin, lyophilized, 0.1 mg
    J9321Injection, epcoritamab-bysp, 0.16 mg
    J9332Injection, efgartigimod alfa-fcab, 2mg
    J9333Injection, rozanolixizumab-noli, 1 mg
    Communication devices and wheelchair accessoriesHCPCSCovered
    E2500Speech generating device, digitized speech, using pre-recorded messages, 8 min. or less
    E2602Gen w/c cushion wdth >=22 in.
    E2613Position back cush wd <22in
    E2374POWER WHEELCHAIR ACCESSORY, HAND OR CHIN CONTROL INTERFACE, STANDARD REMOTE
    Wheelchair accessory codes (examples)HCPCS
    E2390POWER WHEELCHAIR ACCESSORY, FOAM CASTER TIRE, ANY SIZE, REPLACEMENT ONLY, EACH
    E2391POWER WHEELCHAIR ACCESSORY, SOLID (RUBBER/PLASTIC) CASTER TIRE (REMOVABLE), ANY
    E2221Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each
    Implantable device and infusion pump codes (examples)CPT | HCPCS
    C9807Nerve stimulator, percutaneous, peripheral, including electrode and disposable components
    C1820Generator, neurostimulator (implantable), with rechargeable battery and charging system
    B9002Enteral nutrition infusion pump, any type
    Sample device and procedure codes (partial)mixed
    C9796Repair of enterocutaneous fistula small intestine or colon with plug
    C9807Percutaneous peripheral nerve stimulator (including electrode and disposables)
    E0113Crutch Underarm Each Wood
    Device programming and interrogation T-codesCPT
    0926TProgramming device evaluation (in person) with iterative adjustment
    0928TInterrogation device evaluation (remote), up to 90 days
    Representative drug and procedure codes requiring prior authorizationmixed
    J2357Injection, omalizumab, 5 mg
    J2502Injection, pasireotide long acting, 1 mg
    J2323Injection, natalizumab, 1 mg
    0717TAutologous adipose-derived regenerative cell (ADRC) therapy for partial thickness rotator cuff tear
    Examples from partmixed
    0440TAblation, percutaneous, cryoablation, includes imaging guidance; nerve plexus or other truncal nerve
    37243Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation
    64640Destruction, Neurolytic; Other Peripheral Nerve/Branch.

    What Providers Must Do

    Prior Authorization

    Prior Authorization Required — sample codes from list

    Prior authorization is required before providing the listed procedure codes and their described services (examples include 97129, 90913, 90901, 92507, 92508, 97110, 97035, 97033, 97026, 97024, 97018, 97016, 96001). Providers must submit a prior authorization request for these codes to obtain approval before delivering services.

    • Examples from the list: 97129 (therapeutic cognitive interventions), 90913 and 90901 (biofeedback), 92507/92508 (speech therapy), 97110 (therapeutic exercises), 97035 (therapeutic ultrasound).
    Prior Authorization

    Prior authorization required for listed tests

    Prior authorization is required for the enumerated genetic, genomic, and molecular pathology tests shown in the policy excerpt (e.g., 0318U, 0314U, 0300U, 0297U, 0278U, 0339U, 0336U, 0334U, 0329U). Submit prior authorization for these tests before ordering or performing them.

    • Sample listed tests: 0318U (whole genome methylation analysis, pediatrics), 0314U (35-gene mRNA profiling for melanoma), 0300U (whole genome sequencing + optical mapping).

    Definitions and Notes

    inv-83: Prior Authorization — Requirement that the listed procedure codes obtain approval before services are provided (implied by title and content listing codes that require authorization).
    DefinitionPrior authorization — payer-required approval that must be obtained for the listed procedure codes before services are provided or claims are submitted.
    ScopeApplies to the Medicare procedure/HCPCS/CPT/PLA/U-code listings enumerated in this document (updated 2/11/2026).
    Provider actionProviders must request and receive prior authorization for items/services that match the listed procedure codes prior to provision of services.
    Document contextThis entry is part of a code list that identifies items and services requiring prior authorization (partial excerpt of a longer list).
    inv-84: Targeted genomic sequence analysis panel — Genomic sequence analysis panel definition reference.

    Panel Thresholds, Dose Limits, and Other Coding Notes

    Document Updates

    Updated : 2/11/2026policy_updateLatest

    Multiple pages of the prior authorization code list were updated and display 'Updated : 2/11/2026' as the list timestamp; providers should check the update timestamp when submitting prior authorization requests.

    Policy Summary
    PayerBlue Cross Blue Shield - Wisconsin
    PolicyItems and services requiring prior authorization
    Policy CodePolicy N/A
    Change TypeAdministrative update (no material coverage change)
    Effective DateFeb 11, 2026
    Last ReviewFeb 11, 2026
    Next Review DateFeb 11, 2026
    Key ActionObtain prior authorization before providing or submitting claims for any procedure code listed in this document.
    SourceLink
    On This Page
    Items and Services Requiring Prior AuthorizationCode Tables and ExamplesWhat Providers Must DoDefinitions and NotesPanel Thresholds, Dose Limits, and Other Coding NotesDocument Updates
  1. Cytogenetics / structural variant detection: Genome/exome and optical mapping procedures (examples: 0567U, 0214U, 0264U) require prior authorization.
  2. ALL of the following

    • This excerpt contains code listings only; specific clinical criteria or documentation requirements for approval are not present here and must be obtained from the full policy.
    Professional, DME, device, and programmatic codes across these chunks are included on the prior authorization list; see the full policy for clinical/submission details.
    This is a partial code set excerpt; providers should reference the full code listing and clinical criteria in the complete policy for authorization decisions.
    Approval of these items will depend on the full policy's clinical criteria, including unit measures for biologic products and maximum cell counts for CAR-T entries; consult the complete policy for details.
    This excerpt lists categories and representative codes only; providers should use the full policy for the applicable clinical coverage criteria and authorization submission steps.
    Coverage of these procedures and supplies depends on the full clinical coverage criteria and documentation requirements set forth in the complete policy.
    This partial list demonstrates the variety of code systems included; refer to the full policy for specific coverage rules and required supporting documentation.
    Prior Authorization

    Prior authorization required

    Prior authorization is required for the long list of Medicare procedure codes and associated molecular/genomic analyses, multianalyte algorithmic assays, specialized laboratory tests, and selected devices/materials enumerated in the document (e.g., 81235, 81302, 81425, 0215U, 81599, multiple U-codes). Providers must obtain authorization prior to service delivery.

    • Representative codes in this segment: 81235 (EGFR gene analysis), 81302 (MECP2 full sequence), 81425 (genome sequence analysis), 0215U (whole exome/mitochondrial analysis), 81599 (unlisted multianalyte assay).
    Prior Authorization

    Prior authorization required for listed Medicare procedure codes

    Providers must request prior authorization for the specified Medicare procedure codes shown with descriptions (examples include 0469U, 0465U, 0454U). Authorization is required before performing services corresponding to these codes.

    • Examples: 0469U (whole genome sequence analysis for chromosomal abnormalities), 0465U (DNA methylation/oncology assay), 0454U (optical structural variant identification).
    Prior Authorization

    Molecular pathology and oncology panels prior authorization

    Additional molecular pathology and oncology panel tests (including tissue in situ hybridization and specified U-codes and molecular pathology levels) require prior authorization; providers must submit requests for these tests prior to service.

    • Examples: 88365 (Tissue In Situ Hybridization), 0179U (cell-free DNA targeted seq, 23 genes), 81404 (molecular pathology procedure level 5).
    Prior Authorization

    Prior Authorization Requirement - segment

    This document segment identifies multiple items and services (molecular/genetic tests, injections, implants, biosimilars, immune globulins, radiation delivery, and select procedure codes) that require prior authorization; providers must follow the payer's prior authorization process before providing these services.

    • Category-level requirement: molecular/genetic tests, injectable biologics, implants, DME, and radiation/procedure codes listed in this segment.
    Prior Authorization

    Prior Authorization Required Items (section)

    This section enumerates items and services that require prior authorization (numerous Medicare procedure codes and descriptions). Providers must obtain prior authorization for items listed in this section before service or claim submission.

    • The section contains numerous code entries across clinical categories that require prior authorization; see specific codes elsewhere in the list for examples.
    Prior Authorization

    Prior Authorization Required Codes (partial list)

    The policy lists numerous procedure and HCPCS/CPT codes and descriptions that require prior authorization. Providers must submit authorization requests for any services billed with the listed codes.

    • This is a partial list; examples appear throughout the document (see molecular tests, injectable drugs, DME, implants).
    Prior Authorization

    Prior authorization required — code list (partial)

    This portion of the document enumerates specific procedure codes and descriptions that require prior authorization; providers should check the listed codes and request authorization prior to providing the service.

    • Sample entries include J1743 (galsulfase), J1809 (idursulfase), K0007 (extra heavy duty wheelchair), Q4420 (Nuform).
    Documentation Required

    Update notice

    Check the update timestamp shown on many list entries (Updated: 2/11/2026) when preparing and submitting prior authorization requests; the policy's code listings reflect this update date.

    • Multiple chunks in the document display "Updated : 2/11/2026"—verify the current list before submission.
    Prior Authorization

    Prior authorization required — listed procedure codes

    Providers must obtain prior authorization for the Medicare procedure codes listed in chunks 144–145 (examples include K0849, K0859, K0884, L4055, L5910, L5926, L6880, L7009, L7191, Q4225, Q4232, Q4268, Q4273). Submit authorization requests before providing these items.

    • Representative codes: K0849 (power wheelchair group 3 captains chair), L6880 (electric hand/myoelectric digits), Q4225 (AmnioBind, per sq cm).
    Prior Authorization

    Additional prior authorization codes

    Additional J-, Q-, S- and T-codes listed in the policy require prior authorization; providers must include these codes in prior authorization submissions when applicable (examples include J9245, J9326, Q4400, T2039, Q4386, Q4406, S5130, S9480, S5165).

    • Examples: J9245 (melphalan), J9326 (telisotuzumab vedotin), Q4400 (Polygon3 membrane), T2039 (vehicle modifications).
    Prior Authorization

    Hemophilia and intra-articular injection codes

    Hemophilia factor products and intra‑articular hyaluronan injections shown in the list (multiple J-codes such as J7195–J7212 and hyaluronan J7321–J7331 series) require prior authorization; obtain authorization before dispensing or administering.

    • Hemophilia and factor examples: J7195 (factor IX), J7200–J7203 series; Hyaluronan examples: J7324–J7331 (intra-articular hyaluronan derivatives).
    Prior Authorization

    Prior authorization — listed Q-codes and injections

    Prior authorization is required for the listed Q-codes representing biosimilars, amniotic/biologic wound products, and other injectable products (e.g., Q4366, Q4367, Q4369, Q4391, Q5099, Q5100, Q5108, Q5124, Q5126, Q5129, Q5134, Q5147–Q5155, Q9997–Q9999).

    • Examples: Q4366 (Dual Layer Amnio Burgeon X‑Membrane), Q5099 (ustekinumab biosimilar), Q5108 (pegfilgrastim biosimilar).
    Prior Authorization

    Prior authorization — CAR-T/cell therapies

    Prior authorization is required for CAR‑T and cell‑therapy Q-codes and associated services; the listing includes therapeutic‑dose limits and leukapheresis/dose preparation (e.g., Q2042, Q2053, Q2055, Q2056, Q2057, Q2058).

    • Examples: Q2042 (tisagenlecleucel, up to 600M CAR‑positive T cells), Q2053 (brexucabtagene autoleucel, up to 200M CAR‑positive T cells) — authorization required per therapeutic dose.
    Prior Authorization

    Prior authorization — power wheelchairs and complex DME

    Prior authorization is required for the listed power wheelchair, power mobility, and complex DME HCPCS/K codes (many K- and K0-series codes such as K0838, K0842, K0843, K0848, K0850–K0864, K0868–K0886, K0890–K0899, K1007). Providers must submit authorization before ordering or providing these items.

    • Representative codes: K0838 (power wheelchair group 2 heavy duty), K0842 (group 2 standard), K0886 (group 4 heavy duty), K0899 (power mobility device not otherwise classified), K1007 (bilateral HKAFO powered device).
    Prior Authorization

    Prior authorization — prosthetics, orthotics, neurostimulation, cochlear devices

    A broad set of prosthetic, orthotic, neurostimulator, cochlear, myoelectric and related L‑codes require prior authorization (examples include L8680, L8687, L8692–L8693, L8701–L8702, L6925, L6935, L6945, L6955, L6965, L6975, L7045, L7180–L7190, L8686, L8045, L8619, L8623, L8627–L8628 and numerous additional L‑codes).

    • Examples: L8680 (implantable neurostimulator electrode), L8687 (implantable neurostimulator pulse generator), L8619 (cochlear implant external speech processor replacement), L8701–L8702 (powered upper extremity ROM assist devices).
    Prior Authorization

    Prior authorization — DME/power mobility and wheelchair components

    Prior authorization is required for specified DME/power mobility HCPCS/K codes and wheelchair components (examples include K0886, K0890, K0891, K0898, K0899, K1007 and orthosis/part codes such as L0112, K0045, K0052, K0056, K0065).

    • Examples: K0886 (power wheelchair group 4 heavy duty multiple power option), K0890/K0891 (power wheelchair group 5 pediatric codes), K0045 (footrest complete assembly replacement).
    Prior Authorization

    Prior authorization — injectable drugs and biologics

    Prior authorization is required for the injectable medications and biologics listed (selected J‑codes such as J9210, J9216, J9248, J9272, J9274, J9294, J9296, J9297, J9304, J9314, J9319, J9321, J9332, J9333, J9334, J9347, J9348, etc.). Providers must secure authorization before administration or billing.

    • Examples: J9210 (emapalumab), J9319 (romidepsin), J9321 (epcoritamab), J9332 (efgartigimod alfa), J9333 (rozanolixizumab).
    Prior Authorization

    Prior authorization — professional/skilled services

    Prior authorization is required for specified professional and skilled service codes (including G‑ and service codes for skilled nursing/training and partial hospitalization services such as G0493, G0494, G0495, G0496 and H0035).

    • Examples: G0493–G0496 (skilled observation/training services), H0035 (partial hospitalization).
    Prior Authorization

    Prior authorization — communication devices and wheelchair seating

    Prior authorization is required for speech‑generating devices, wheelchair cushions/positioning items, and related accessories listed (e.g., E2506, E2508, E2511, E2602, E2604, E2605–E2626). Obtain authorization before providing these devices or accessories.

    • Examples: E2506 (speech generating device digitized speech >40 min), E2508 (synthesized speech), E2602/E2604 (wheelchair cushions).
    Prior Authorization

    Power wheelchair accessory - foam caster tire

    The power wheelchair accessory "POWER WHEELCHAIR ACCESSORY, FOAM CASTER TIRE, ANY SIZE, REPLACEMENT ONLY, EACH" is listed as requiring prior authorization; obtain authorization before replacement accessory supply orders.

    • Medicare descriptor: POWER WHEELCHAIR ACCESSORY, FOAM CASTER TIRE (E2390/E2391 series entries appear in the list).
    Prior Authorization

    Power wheelchair accessories and stretch devices

    Multiple power wheelchair accessories and static/dynamic stretch device codes (E2391–E2398, E1801, E1818, E1821, E1823, E1828–E1831, E1905) require prior authorization; providers must request authorization before supplying these accessories or devices.

    • Examples: E2391 (solid caster tire removable), E2394 (drive wheel replacement), E1801 (static progressive stretch elbow device), E1905 (VR CBT device).
    Prior Authorization

    Monitors and manual wheelchair accessories

    Blood glucose monitors and numerous manual wheelchair accessory codes (E2100, E2101, E2201, E2204–E2219, etc.) are listed as requiring prior authorization; secure authorization prior to provision.

    • Examples: E2100 (blood glucose monitor with voice synthesizer), E2216–E2219 (manual wheelchair foam/foam-filled tires/accessories).
    Prior Authorization

    Complex wheelchair and pediatric wheelchair codes

    Complex wheelchair accessories, pediatric wheelchair codes, and power seating/standing system accessories (E2221, E2224–E2227, E2292–E2313, E1195, E1221–E1240, E1270–E1298) require prior authorization; obtain prior authorization before ordering these items.

    • Examples: E2221 (manual wheelchair solid caster tire), E2298 (complex rehabilitative power wheelchair accessory—power seat elevation), E2301 (power standing system).
    Prior Authorization

    DME, dialysis equipment, and wheelchair accessories

    Durable medical equipment miscellaneous, dialysis equipment, and additional wheelchair accessories listed (E1399, E1500, E1540, E1550, E1560, E1570, E1580, E1590, E1600, E1610, E1620, E1632, E1635, E1701, E1702, etc.) require prior authorization prior to provision.

    • Examples: E1399 (DME miscellaneous), E1570 (adjustable chair for ESRD), E1632 (wearable artificial kidney), E1701/E1702 (jaw motion cushions/measurement devices).
    Prior Authorization

    Seating systems, wheelchair mods, and stimulators

    Power seating systems, wheelchair modifications, ambulatory devices, external stimulators, and related devices (E1002–E1034, E1060, E1083–E1093, E1160–E1180, E0743–E0764, E0770–E0830) require prior authorization; providers must request authorization before ordering or delivering these items.

    • Examples: E1002 (power seating tilt only), E1006 (combination tilt/recline), E1032/E1033 (manual swingaway mounting hardware), E0743 (external lower extremity nerve stimulator).
    Prior Authorization

    Traction, monitoring, compression, and nerve stimulation devices

    Traction devices, monitors, standing frames, pneumatic appliances, compression pumps, and TENS/non‑invasive nerve stimulators listed (E0840–E0959, E0610–E0638, E0720–E0735) require prior authorization; secure authorization before providing these devices or services.

    • Examples: E0735 (non‑invasive vagus nerve stimulator), E0638 (standing frame/table system), E0720/E0730 (TENS devices).
    Prior Authorization

    Beds, oxygen, phototherapy, and hydrotherapy equipment

    Hospital and pediatric beds, phototherapy units, hydrocollator units, oxygen systems, and related items (e.g., E0300, E0316, E0329, E0350, E0425, E0447, E0455, E0483, E0175–E0239 series) require prior authorization prior to provision.

    • Examples: E0300 (pediatric crib hospital grade), E0447 (portable oxygen contents), E0236/E0239 (hydrocollator unit portable/replacement pads), E0265–E0266 (hospital bed total electric).
    Prior Authorization

    Implants, neurostimulators, radiopharmaceuticals, and infusion/feeding pumps

    Implantable procedures, neurostimulator generators, radiopharmaceuticals, enteral/parenteral infusion pumps and feeding supplies listed (C9796, C9807, C9808, D7996, E0113, C8003, C9047, C9145, C9360, C9727, B9002, B9006, C1734, C1736, C1764, C1820, A9543, A9580, A9590, A9607, B4034–B4036) require prior authorization before implantation, infusion or device provision.

    • Examples: C9807 (percutaneous peripheral nerve stimulator), C1820 (implantable neurostimulator generator), B9002 (enteral nutrition infusion pump), A9607 (lutetium Lu‑177 therapeutic).
    Prior Authorization

    Prior Authorization requirement — listing

    This section lists the Medicare procedure codes and descriptions that require prior authorization; providers should reference the enumerated codes and request authorization prior to delivering the corresponding services.

    • The listing covers a broad set of device, procedure, drug, and test codes—see the document's specific code entries for operational detail.
    Prior Authorization

    Behavioral and testing services

    Behavioral, psychological, and neuropsychological testing and therapy codes (e.g., 96130, 96132, 96136, 96137, 96138, 96139) are included in the list and require prior authorization; obtain authorization prior to providing these services.

    • Examples: 96130/96132 (psychological/neuropsych testing evaluation), 96136/96137/96138/96139 (test administration and scoring by professional/technician).
    Prior Authorization

    Transplant and VAD/heart procedures

    Major transplant procedures and mechanical circulatory support (VAD/heart) procedures (e.g., codes listed such as 47145, 44720, 44132, 44136, 33982, 33927, 33945) require prior authorization; providers must obtain authorization before performing transplant or VAD/heart operations.

    • Examples: 47145 (hepatectomy preparation/maintenance of allograft), 38206/38240 (hematopoietic progenitor cell harvesting/transplantation), 33982/33927/33945 (VAD/heart implant/replacement/transplant codes).
    Prior Authorization

    Prior Authorization Required Codes (partial list)

    This partial list contains numerous procedure and drug codes that require prior authorization; providers should consult the full policy for complete code listings and submit prior authorization requests accordingly.

    • The partial list includes T‑codes, CPT codes, HCPCS/J‑codes and other identifiers across device, drug, and procedure categories.
    Prior Authorization

    Prior Authorization required items (partial list)

    This part of the policy lists items and services that require prior authorization (the part contains numerous Medicare procedure codes and descriptions). Providers must secure authorization for any listed item before service delivery.

    • Examples in this segment include 0440T (percutaneous cryoablation), 37243 (vascular embolization), 64640 (neurolytic destruction of peripheral nerve), and multiple advanced imaging and procedure codes.
    Term
    Targeted genomic sequence analysis panel — a genomic sequence analysis panel focused on specific genes relevant to a clinical indication (examples in the list include solid organ neoplasm panels and disease‑specific panels).
    Typical contentMay interrogate sequence variants, copy number variants, microsatellite instability, and/or RNA when performed (per listed descriptions).
    Example codesExamples include 81455 (targeted genomic sequence analysis panel, 51+ genes) and 81449 (5–50 gene targeted panel).
    inv-85: Drug metabolism genomic panel — Drug metabolism (pharmacogenomics) panel must include testing of at least 6 genes including CYP2C19, CYP2D6, and CYP2D6 duplication/deletion as applicable.
    RequirementDrug metabolism genomic panel — must include testing of at least 6 genes and specifically include CYP2C19 and CYP2D6 (including CYP2D6 duplication/deletion analysis as applicable).
    Example codeText description tied to drug metabolism panels in the code list (see relevant Medicare procedure entries).
    Related entriesMultiple CYP2D6 and pharmacogenomics entries are present (eg, 81226 for CYP2D6 gene analysis).
    inv-86: Exome/Genome entries — Exome/genome sequencing entries include primary procedures and comparator or re-evaluation procedures (e.g., comparator exome, re-evaluation).
    Entry typesExome/genome sequencing entries include primary exome/genome procedures and separate comparator or re-evaluation procedure codes (eg, comparator exome entries and re-evaluation of previously obtained exome).
    ExamplesCodes include exome (81415), comparator exome (81416), and exome re-evaluation (81417) as listed in the document.
    PLA/U-code relationPLA and U-code entries for exome/genome analyses (eg, 0215U) appear alongside CPT exome/genome procedure codes in the list.
    inv-87: PLA / U-code — PLA/unique U-codes refer to proprietary laboratory analyses or algorithmic assays (e.g., 0215U, 0019U).
    MeaningPLA / U-code — proprietary laboratory analysis or uniquely identified assay (PLA/U-code) used for specialized or algorithmic laboratory tests (examples in the list: 0215U, 0019U).
    Use casePLA/U-codes represent vendor‑specific or algorithmic multianalyte assays reported separately in the code list.
    Relation to coveragePLA/U-code entries in the document are included among procedure codes requiring prior authorization.
    inv-88: Medicare, Procedure Code — Medicare Procedure Code definition reference.
    DefinitionMedicare, Procedure Code — the numeric or alphanumeric procedure identifier (CPT/HCPCS/U-code/PLA) used to list items and services in this document.
    List formatEntries are presented as 'Medicare, Procedure Code = <code>. Medicare, Description = <description>'.
    ContextCodes span CPT, HCPCS, PLA/U-codes and other Medicare identifiers included in the prior authorization list.
    inv-89: Molecular pathology procedure level — Molecular pathology procedure levels refer to CPT molecular pathology tiered categories.
    DefinitionMolecular pathology procedure level — CPT molecular pathology tiered categories (procedure level entries such as molecular pathology procedure level 4, 5, 9 appear in the list).
    ExamplesEntries include explicit molecular pathology levels (eg, 81403 = Level 4; 81408 = Level 9; 81404 and 81552 referenced as higher-level molecular assays).
    RelevanceThese levels are used to group molecular pathology services in the code listing subject to prior authorization.
    inv-90: Prior authorization items — Procedure code entries (U-codes, CPT and HCPCS) correspond to specific molecular/genetic tests, drug injections, biosimilars, immune globulins, and DME.
    ContentPrior authorization items — the code list includes U-codes, CPT and HCPCS codes corresponding to molecular/genetic tests, PLA algorithmic assays, drug injections (J-codes), biosimilars (Q-codes), immune globulins, and durable medical equipment (E/K/L codes).
    ExamplesSample entries include genetic/genomic tests (eg, 81425, 0215U), injectable biologics (eg, J9312, J9035), biosimilars (eg, Q5107), and DME/device codes (eg, K0849, E2390).
    ActionProviders should match the requested service to the specific procedure code to determine whether prior authorization is required.
    inv-91: Prior authorization definition — Prior authorization is the payer-required approval process for listed items/services prior to provision/claim submission.
    DefinitionPrior authorization — payer-required approval process that must be completed before coverage will be considered for the listed items/services; providers must obtain authorization prior to service delivery or claim submission.
    Date/Update noteDocument and lists in this excerpt show 'Updated : 2/11/2026' — providers should reference the update timestamp when submitting requests.
    ApplicabilityApplies to the Medicare procedure codes and descriptions enumerated in this policy excerpt; specific clinical criteria for approval are not included in this excerpt.
    inv-92: Prior Authorization — Prior Authorization reference (redundant entry in source).
    NotePrior Authorization — The document repeatedly restates that listed items and services require prior authorization before provision or claim submission.
    Provider implicationProviders must verify and obtain prior authorization for any service matching a listed procedure code in this document.
    RecordkeepingUse the Medicare procedure code and exact description from the listing when preparing authorization requests.
    inv-93: Updated : 2/11/2026 — Update timestamp callout present in the document.
    Updated timestampUpdated : 2/11/2026 — this update date is displayed on multiple list pages and applies to the code listings in this excerpt.
    UsageProviders should confirm the update date when submitting prior authorization requests to ensure they reference the current code list.
    Document cadenceEffective/last reviewed/next review all show 2026-02-11 in the brief metadata.
    inv-94: List entry format — Procedure code entries are presented with a Medicare context (Procedure Code = [code]; Description = [text]).
    FormatList entry format — each entry is presented as 'Medicare, Procedure Code = <code>. Medicare, Description = <description>'.
    Code systemsThe list combines CPT, HCPCS, PLA/U-codes and other Medicare identifiers using the same entry format.
    Provider instructionWhen requesting prior authorization, reference the exact 'Procedure Code' and 'Description' as presented in the listing.
    inv-95: Prior Authorization — Restated definition of prior authorization requirement for listed items/services.
    Requirement restatedPrior authorization — Administrative requirement for approval before providing the listed items/services; the list identifies codes subject to this requirement.
    Coverage noteThis excerpt does not include the clinical coverage criteria or documentation requirements for approval; refer to full policy for those details.
    Who is affectedProviders and facilities submitting claims for the listed Medicare procedure codes.
    inv-96: Therapeutic dose (CAR-T) — Includes leukapheresis and dose preparation procedures and dose thresholds referenced in the code listings.
    DefinitionTherapeutic dose (CAR‑T) — CAR‑T procedure entries include leukapheresis and dose preparation procedures and specify per‑dose cell counts for certain Q‑codes.
    ExamplesListed CAR‑T codes specify dose limits (eg, Q2042: up to 600 million CAR‑positive viable T cells; Q2053: up to 200 million).
    Authorization implicationPrior authorization applies to CAR‑T therapy codes including associated leukapheresis and dose preparation procedures.
    inv-97: Unit measures for amniotic/biologic products — Per square centimeter or per cc/unit as specified for amniotic and biologic products in the code list.
    Unit measuresUnit measures for amniotic/biologic products — many listed Q‑codes are billed per square centimeter or per cc/unit (eg, multiple Q4xxx entries list 'per sq cm' or 'per 0.5 cc').
    ExamplesExamples include Q4200 (SkinTE, per sq cm), Q4233 (SurFactor or NuDyn, per 0.5 cc), and numerous other Q‑codes in the list.
    Provider actionWhen requesting prior authorization, include the per‑unit measure (sq cm or cc) as stated in the procedure description.
    inv-98: Prior authorization — Prior authorization requirement: this list identifies Medicare procedure/HCPCS codes that require prior authorization before coverage will be considered.
    DefinitionPrior authorization — this list identifies Medicare procedure/HCPCS codes that require prior authorization before coverage will be considered; authorization must be obtained prior to service.
    Administrative implicationThe listing is an administrative requirement and does not itself define clinical coverage criteria in this excerpt.
    ReferenceProviders should reference the exact procedure code and description from the list when initiating authorization requests.
    inv-99: Speech generating device — Speech generating devices referenced by E2500-E2508 encompass digitized and synthesized speech devices and software.
    DefinitionSpeech generating device — E2500–E2508 entries reference speech generating devices, including digitized and synthesized speech devices and related software.
    ExamplesEntries include E2506 (digitized speech, >40 min), E2508 (synthesized speech with spelling), and E2511 (speech generating software).
    Authorization noteThese device codes are included in the prior authorization list and require authorization prior to provision.
    inv-100: Prior Authorization list (excerpt) — List of items and service that require Prior Authorization (updated 2/11/2026).
    ExcerptPrior Authorization list (excerpt) — this document segment provides a partial list of items and services that require prior authorization (Updated : 2/11/2026).
    Content typeIncludes a mix of CPT, HCPCS (J/Q/E/K/L), PLA/U‑codes and T‑codes across multiple clinical categories.
    ActionConsult the full policy for complete lists and any code‑specific clinical requirements beyond this excerpt.
    inv-101: Medicare, Procedure Code = <code> ; Medicare, Description = <description> — Procedure code listing format.
    Listing conventionProcedure code listing — 'Medicare, Procedure Code = <code> ; Medicare, Description = <description>' is used throughout the document.
    Provider instructionWhen preparing authorization requests, use the exact code and description formatting from the list to avoid ambiguity.
    SystemsCodes include CPT, HCPCS, Q‑codes, J‑codes, PLA/U codes, T‑codes and various Medicare identifiers.
    inv-102: Prior Authorization — Administrative requirement for approval before providing the listed items/services prior to provision/claim submission.
    DefinitionPrior Authorization — administrative approval required from the payer before providing any listed items/services; absence of authorization may affect coverage.
    Operational noteThis excerpt is administrative in nature (code list) and does not include the detailed clinical coverage criteria within this segment.
    Next stepsFor code‑specific coverage rules or documentation requirements, retrieve the full policy or contact the payer authorization unit.
    inv-103: PET/CT note — PET/CT: concurrently acquired positron emission tomography with computed tomography correction note referenced in the document.
    DefinitionPET/CT note — concurrently acquired PET with CT imaging corrects PET spatial resolution limitations by fusing anatomical (CT) and metabolic (PET) data; report codes for limited vs whole‑body PET/CT are included.
    Coding examplesReport 78814 for concurrently acquired PET/CT of a limited area; 78815 and 78816 referenced for broader coverage in the document.
    Authorization implicationPET/CT procedure codes listed are included among services requiring prior authorization.